
Results
11
Large established companies which pay a dividend.
11 companies
Sanofi
Market Cap: €92.3b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SAN
€76.75
7D
1.7%
1Y
-7.0%
Astellas Pharma
Market Cap: JP¥3.9t
Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.
4503
JP¥2,164.50
7D
1.1%
1Y
45.5%
Shionogi
Market Cap: JP¥2.5t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.
4507
JP¥2,865.50
7D
0.9%
1Y
14.9%
Orion Oyj
Market Cap: €10.8b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€76.55
7D
12.7%
1Y
9.8%
Krka d. d
Market Cap: €7.8b
A generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.
KRKG
€260.00
7D
-3.0%
1Y
33.0%
Kyowa Kirin
Market Cap: JP¥1.4t
Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.
4151
JP¥2,620.00
7D
-0.7%
1Y
3.9%
Ono Pharmaceutical
Market Cap: JP¥1.1t
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
4528
JP¥2,413.50
7D
1.0%
1Y
48.6%
China Resources Sanjiu Medical & Pharmaceutical
Market Cap: CN¥41.6b
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
000999
CN¥25.16
7D
-0.2%
1Y
-20.4%
Santen Pharmaceutical
Market Cap: JP¥650.6b
Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.
4536
JP¥1,990.00
7D
-5.3%
1Y
19.2%
Livzon Pharmaceutical Group
Market Cap: CN¥25.0b
Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People’s Republic of China and internationally.
000513
CN¥30.90
7D
-1.3%
1Y
-28.0%
Apeloa PharmaceuticalLtd
Market Cap: CN¥22.7b
Provides raw materials various pharmaceutical factories in the People’s Republic of China and internationally.
000739
CN¥20.84
7D
1.8%
1Y
35.9%